Study S000287
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
Registration
Registered primary outcomes
- Change in body weight [up to 12 weeks of clinical trial]
- The number of good responders to combined treatment regarding body weight [up to 12 weeks of clinical trial]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.